Program Schedule

73
My Toughest Cases and What I Learned From Them

Friday, October 10, 2014: 7:00 AM-8:15 AM
Room: The Pennsylvania Convention Center: 119-AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • identify key aspects of the medical evaluation, diagnosis and treatment of challenging infectious diseases cases, and what made them memorable to seasoned infectious disease clinicians
  • analyze key elements of the infectious diseases doctoring experierence led to further research and clinical practice changes
  • recognize unusual infectious disease-related conditions from the cases presented

Target Audience: Members-in-training, Investigators, Infectious diseases physicians, Health care workers, Fellows, Clinicians, Academicians

Tracks: Adult ID

Moderator:  Francisco Marty, MD, FACP, FIDSA, Brigham and Women's Hospital

Meet-the-professors:  Nesli Basgoz, MD, FIDSA, Massachusetts General Hospital and Eduardo Gotuzzo, MD, Universidad Peruana Cayetano Heredia

Presentations:
7:30 AM
561
Meet-the-Professor
Eduardo Gotuzzo, MD

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 CreditTM

ACPE Credits: No CPE credit is offered for this session.

ACPE Number:

Disclosures:

F. Marty, Astellas: Grant Investigator, Research support
Chimerix: Grant Investigator, Research support
Merck: Consultant, Consulting fee
Vertex: Consultant, Consulting fee
WHISCON: Grant Investigator, Research support
Alexion: Consultant, Consulting fee
Gilead: Consultant, Consulting fee
ViroPharma: Grant Investigator, Research support
GlaxoSmithKline: Grant Investigator, Research support

N. Basgoz, None

E. Gotuzzo, PFIZER: Board Member and Grant Investigator, Grant recipient and Speaker honorarium
jOHNSON jOHNSON: Grant Investigator, Consulting fee and Grant recipient

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek